About
Contact & Profiles
A5030678825
Research Areas
- Respiratory Support and Mechanisms
- Central Venous Catheters and Hemodialysis
- COVID-19 Clinical Research Studies
- Neonatal Health and Biochemistry
- Cystic Fibrosis Research Advances
- Sepsis Diagnosis and Treatment
10.1007/s40121-022-00690-0
article
EN
Infectious Diseases and Therapy
2022-10-15
Vidofludimus calcium has shown anti-inflammatory effects in clinical trials of autoimmune diseases and recently demonstrated antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We performed a double-blind, randomized, placebo-controlled, phase trial to evaluate the safety efficacy vidofludimus patients hospitalized for disease-19 (COVID-19) Europe United States. Patients aged ≥18 who positive COVID-19 were randomized (1:1) receive placebo or 45 mg 14 days...
10.2139/ssrn.4082907
article
EN
SSRN Electronic Journal
2022-01-01
Coming Soon ...